Quick Answer
Guardant Health, Inc. reported Common Stock Shares Outstanding of 130.64 million shares for the year ending 2025.
- Guardant Health, Inc. showed an increase of +5.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: 13.00 million shares | Q1 2019: 86.10 million shares | Q2 2019: 92.81 million shares | Q3 2019: 93.85 million shares | Q1 2020: 94.51 million shares | Q2 2020: 99.31 million shares | Q3 2020: 99.90 million shares | Q1 2021: 101.09 million shares | Q2 2021: 101.27 million shares | Q3 2021: 101.62 million shares | Q1 2022: 101.90 million shares | Q2 2022: 102.19 million shares | Q3 2022: 102.41 million shares | Q1 2023: 102.71 million shares | Q2 2023: 117.66 million shares | Q3 2023: 117.85 million shares | Q1 2024: 121.79 million shares | Q2 2024: 122.97 million shares | Q3 2024: 123.16 million shares | Q1 2025: 123.65 million shares | Q2 2025: 124.48 million shares | Q3 2025: 125.01 million shares.
- Over the full 9 years of available data (2017 to 2025), Guardant Health, Inc.'s Common Stock Shares Outstanding has grown by 998.1%.
- Historical annual values: Fiscal year 2025: 130.64 million shares | Fiscal year 2024: 123.99 million shares | Fiscal year 2023: 121.63 million shares | Fiscal year 2022: 102.62 million shares | Fiscal year 2021: 101.77 million shares | Fiscal year 2020: 100.21 million shares | Fiscal year 2019: 94.26 million shares | Fiscal year 2018: 85.83 million shares | Fiscal year 2017: 11.90 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: